Multinational drug manufacturer GlaxoSmithKline (GSK) has joined the search for an HIV vaccine, with a promise to make an effective product affordable to developing nations.
The company announced on Tuesday that it was setting up a joint research team with the International AIDS Vaccine Initiative in the first public-private partnership involving a major pharmaceutical company.
Jean Stephenne, the president of GSK Biological, the company's vaccines arm, said in a statement, "The private sector has an immense amount of knowledge, resources and expertise; innovative partnerships such as this are essential to tackle the biggest global health challenges."
This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions
Share this article